GRIFOLS | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Alcon AG USD 1.41B 4M 2025-06
Almirall EUR 374.4M 2.7M 2025-03
Amadeus IT EUR 1.49B 444.3M 2025-03
Amarin USD 119.52M 1.51M 2025-03
argenx SE 2.09B 586.04M 2025-06
AstraZeneca USD 7.06B 1.83B 2025-06
Bayer EUR 4.56B 542M 2025-06
Cie Automotive EUR 486.62M 9.22M 2024-12
Demant 1.14B 30M 2025-06
Ence Energia y Celulosa EUR 318.8M 79.9M 2024-09
Essilor EUR 2.25B 86M 2024-12
Ferrovial EUR 4.81B 1.17B 2024-12
Fresenius EUR 1.23B 1.16B 2025-06
Fresenius Medical Care EUR 1.72B 644.08M 2025-06
Galapagos EUR 108.07M 43.83M 2025-03
Genmab DKK 1.3B 323M 2025-06
GlaxoSmithKline GBP 3.6B 865M 2025-06
GRIFOLS EUR 558.69M 194.13M 2025-06
Hikma Pharmaceutical USD 188M 188M 2024-12
Inditex EUR 5.97B 409M 2025-04
Merck EUR 1.17B 161M 2025-06
Novartis USD 6.66B 410M 2025-06
Philips EUR 1.82B 629M 2025-06
Roche Holding CHF 6.98B 2.15B 2024-12
Sanofi 15.36B 7.37B 2025-06
UCB EUR 1.57B 1.14B 2024-12
Viscofan EUR 46.53M 24.9M 2025-06


GRIFOLS Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.